Failure of pre-exposure prophylaxis with on-demand tenofovir disoproxil fumarate/emtricitabine resulting in emergence of antiretroviral resistance

被引：0
|
作者：
Hsiao, Yu-Yu [1 ]
Huang, Yi-Chia [2 ]
Chang, Sui-Yuan [3 ,4 ,5 ]
Kuo, Ching-Hua [6 ]
Chang, Shu-Fang [3 ]
Lin, Ya-Ting [6 ]
Luo, Yu-Zhen [7 ]
Lee, Yu-Lin [1 ]
Hung, Chien-Ching [5 ,8 ,9 ]
机构：
[1] Changhua Christian Hosp, Dept Internal Med, 135 Nanxiao St, Changhua 50006, Taiwan
[2] Natl Taiwan Univ Hosp Biomed Pk, Dept Internal Med, Hsinchu, Taiwan
[3] Natl Taiwan Univ, Coll Med, Dept Clin Lab Sci & Med Biotechnol, Taipei, Taiwan
[4] Natl Taiwan Univ Hosp, Dept Lab Med, Taipei, Taiwan
[5] Natl Taiwan Univ, Coll Med, Taipei, Taiwan
[6] Natl Taiwan Univ, Sch Pharm, Taipei, Taiwan
[7] Natl Taiwan Univ Hosp, Ctr Infect Control, Taipei, Taiwan
[8] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei, Taiwan
[9] Natl Taiwan Univ Hosp, Dept Trop Med & Parasitol, Taipei, Taiwan
来源：
JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION | 2021年 / 54卷 / 04期
关键词：
HIV infection; Nucleic-acid amplification test; Resistance-associated mutation; Combination antiretroviral therapy;
D O I：
10.1016/j.jmii.2021.01.011
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：755 / 757
页数：3
相关论文
共 50 条
  • [41] Reversibility of Glomerular Renal Function Decline in HIV-Uninfected Men and Women Discontinuing Emtricitabine-Tenofovir Disoproxil Fumarate Pre-Exposure Prophylaxis
    Mugwanya, Kenneth K.
    Wyatt, Christina
    Celum, Connie
    Donnell, Deborah
    Kiarie, James
    Ronald, Allan
    Baeten, Jared M.
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2016, 71 (04) : 374 - 380
  • [42] Does tenofovir disoproxil fumarate/emtricitabine for HIV pre-exposure prophylaxis induce changes in kidney function in people older than 50 years old?
    Novela, Francisco
    Faria, Flavia
    Pos, Ema
    Almeida, Soraia
    Cipriano, Ana
    Mendez, Josefina
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2024, 27 : 43 - 44
  • [43] Changes in renal function associated with oral emtricitabine/tenofovir disoproxil fumarate use for HIV pre- exposure prophylaxis
    Solomon, Marc M.
    Lama, Javier R.
    Glidden, David V.
    Mulligan, Kathleen
    McMahan, Vanessa
    Liu, Albert Y.
    Vicente Guanira, Juan
    Veloso, Valdilea G.
    Mayer, Kenneth H.
    Chariyalertsak, Suwat
    Schechter, Mauro
    Bekker, Linda-Gail
    Kallas, Esper Georges
    Burns, David N.
    Grant, Robert M.
    AIDS, 2014, 28 (06) : 851 - 859
  • [44] Tenofovir disoproxil fumarate as pre-exposure prophylaxis for HIV prevention in women with osteoporosis: a case report and review of the literature
    Patel, Rupa R.
    Presti, Rachel
    Harrison, Laura C.
    Powderly, William G.
    Chan, Philip A.
    ANTIVIRAL THERAPY, 2018, 23 (04) : 379 - 382
  • [45] Acceptability of a Tenofovir Disoproxil Fumarate Intravaginal Ring for HIV Pre-Exposure Prophylaxis Among Sexually Active Women
    Dobkin, April
    McWalters, Jessica
    Barnett, Rebecca
    Ray, Laurie L.
    Espinoza, Lilia
    McGinn, Aileen P.
    Atrio, Jessica M.
    Keller, Marla J.
    SEXUALLY TRANSMITTED DISEASES, 2020, 47 (12) : 819 - 824
  • [46] Phase 3 randomized, controlled DISCOVER study of daily emtricitabine/tenofovir alafenamide (F/TAF) or emtricitabine/tenofovir disoproxil fumarate (F/TDF) for HIV pre-exposure prophylaxis (PrEP): week 96 results
    Ruane, P. J.
    Clarke, A.
    Post, F. A.
    Schembri, G.
    Jessen, H.
    Trottier, B.
    Bergin, C.
    Molina, J-M
    Wong, P.
    Ebrahimi, R.
    Brainard, D. M.
    Osinusi, A.
    Das, M.
    McCallister, S.
    HIV MEDICINE, 2019, 20 : 95 - 96
  • [47] No observed bidirectional effect between tenofovir diphosphate concentrations and gender-affirming hormone concentrations among transgender persons switching from tenofovir disoproxil fumarate/emtricitabine to tenofovir alafenamide/emtricitabine for HIV pre-exposure prophylaxis
    Patel, Nimish
    Morris, Sheldon
    Burke, Leah
    Chow, Karen
    Pacheco, Deedee
    Anderson, Peter
    Stancyzk, Frank
    Blumenthal, Jill
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2024, 90 (10) : 2360 - 2365
  • [48] Assessing drug resistance emergence in a macaque model of antiretroviral pre-exposure prophylaxis
    Dobard, C.
    Masciotra, S.
    Lipscomb, J.
    Youngpairoj, A.
    Cong, M.
    Sharma, S.
    Johnson, J. A.
    Garcia-Lerma, J. G.
    Heneine, W.
    ANTIVIRAL THERAPY, 2010, 15 : A165 - A165
  • [49] Association of Vitamin D Insufficiency and Protective Tenofovir Diphosphate Concentrations with Bone Toxicity in Adolescent Boys and Young Men Using Tenofovir Disoproxil Fumarate/Emtricitabine for HIV Pre-Exposure Prophylaxis
    Havens, Peter L.
    Tamhane, Ashutosh
    Stephensen, Charles B.
    Schuster, Gertrud U.
    Gordon, Catherine M.
    Liu, Nancy
    Wilson, Craig M.
    Hosek, Sybil G.
    Anderson, Peter L.
    Kapogiannis, Bill G.
    Mulligan, Kathleen
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2019, 35 (02) : 123 - 128
  • [50] Tenofovir disoproxil fumarate associated Fanconi syndrome in an HIV-uninfected man receiving HIV pre-exposure prophylaxis
    Dube, M. P.
    Funk, C. A.
    Corado, K.
    Morris, S.
    ANTIVIRAL THERAPY, 2016, 21 : A57 - A57
12345